The second and final reading of the Markit U.S. manufacturing index totaled 53.9 in December, down from 54.8 in November, the privately run firm said Friday.
The pace of growth in the U.S. manufacturing sector slowed more than expected in December, according to an industry report released on Friday.
A collapse in oil prices won't derail the railroads' profit engine even if it does slow the tremendous growth in crude shipments seen in recent years.
The Obamas are closing out their Hawaii vacation at one of the ritziest joints on Oahu.
The bacteria that cause cholera grab genes from other organisms in a particularly predatory and precise way, new research finds: They spear neighboring cells with a kind of poison-tipped spike.
If a space rock were to hit the Earth at just the right location in the oceans, it could cause massive waves that could inundate U.S.
You might not be able to physically step inside the monumental tomb discovered this past summer in Amphipolis, Greece, but there are plenty of unofficial places to go on the Internet to pretend you're doing just that
Shares of some top homebuilders companies are mixed at 10 a.m.: DR Horton fell $.06 or .2 percent, to $25.23.
Shares of some top railroad companies are down at 10 a.m.: CSX fell $.14 or .4 percent, to $36.09.
Shares of some top computer companies are mixed at 10 a.m.: Apple Inc s fell $.86 or .8 percent, to $109.52.
Shares of some top telecom companies are up at 10 a.m.: AT&T Inc. rose $.20 or .6 percent, to $33.79.
Shares of some top medical devices companies are mixed at 10 a.m.: Allergan rose $1.84 or .9 percent, to $214.43.
Shares of some top utilities companies are up at 10 a.m.: American Electric Power Co. rose $.14 or .2 percent, to $60.86.
Shares of some top insurance companies are up at 10 a.m.: ACE L rose $.47 or .4 percent, to $115.35.
A Utah mother of six who delayed cancer treatment in an effort to save her unborn child died at her home Wednesday, after initially being told in October that she had just 24 to 36 hours to live.
London copper slipped on Friday to trade near last week's 4-1/2 year low, pressured by a strong dollar and indications of slowing economic growth in China.
Rite Aid's revenue from established stores climbed more than 5 percent last month, as growing prescription totals countered a hit from cheaper generic drugs for the nation's third-largest drugstore chain.
Harvest Natural Resources cancelled the $275 million sale of its remaining assets in Venezuela after failing to garner approval from country's beleaguered government.
A sharp slowdown in government-built schools and infrastructure caused U.S. construction spending to fall slightly in November.
The Food and Drug Administration approved 41 first-of-a-kind drugs in 2014, including a record number of medicines for rare diseases, pushing the agency's annual tally of drug approvals to its highest level in 18 years.